Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1897 - 1904 of 12089 results
IRA Update: IRS Releases Limited Guidance on Low-Income Community Adder and Establishes Allocation Program Needed to Make the Adder Available
February 16, 2023| Alert| Viewpoint
Ruling Casts Shadow On Cannabis Employees' Ch. 13 Relief
February 16, 2023| News
Lensa: Are AI Art Generators Copyright Infringers?
February 15, 2023| Blog| Viewpoint
Navigating Fiduciary Duties amidst the Rise of Anti-ESG Rulemaking
February 15, 2023| Blog| Viewpoint
Reinventing the Employment Relationship: A Moderated Discussion about the Future of Work
February 15, 2023| Podcast| Viewpoint
MintzTech Connect Industry News: Spotlight on Moolah Kicks
February 15, 2023| Article| Viewpoint
Delaware Court of Chancery Extends the Fiduciary Duty of Oversight (i.e., Caremark Claims) to Corporate Officers
February 15, 2023| Blog| Viewpoint
Health Care Deal Structures: What Will the Deal Look Like?
February 15, 2023| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|